K200279

Substantially Equivalent

ImmunoCAP Allergen o215, Component nGal-alpha-1,3-Gal(alpha-Gal) Thyroglobulin, bovine

Applicant: Phadia AB
Product code: DHB
Advisory panel: Immunology
Date received: 2020-02-04
Decision date: 2020-05-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Uppsala, SE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.